Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.

One major prerequisite for an orally administered drug is the ability to cross the intestinal epithelia from intestinal lumen into the blood circulation. Therefore, the absorption potential of molecules is studied early on during the drug development process. Permeation experiments using cultured cell monolayers are one of the most often applied methods to screen and also to predict in more detail the intestinal absorption potential of molecules in preclinical phase. Furthermore, these studies are also used to screen the molecules for transporter interactions as well as for more detailed mechanistic studies of the transfer routes involved. Several mathematical and computational models with complexity varying from simple non-mechanistic single barrier models to mechanistically more detailed compartmental models have been developed to describe the drug disposition during these in vitro permeation experiments. This MiniReview gives an overview of these models and their applications. Also the implications of these models to the prediction of intestinal absorption in vivo are discussed.

[1]  G. Koren,et al.  Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. , 1999, American journal of physiology. Renal physiology.

[2]  P. Artursson,et al.  Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  K. Pang,et al.  Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[4]  K. Luthman,et al.  Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.

[5]  Lawrence X. Yu,et al.  Mechanistic Approaches to Predicting Oral Drug Absorption , 2009, The AAPS Journal.

[6]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[7]  D. Thakker,et al.  Efflux Ratio Cannot Assess P-Glycoprotein-Mediated Attenuation of Absorptive Transport: Asymmetric Effect of P-Glycoprotein on Absorptive and Secretory Transport Across Caco-2 Cell Monolayers , 2003, Pharmaceutical Research.

[8]  G L Amidon,et al.  A compartmental absorption and transit model for estimating oral drug absorption. , 1999, International journal of pharmaceutics.

[9]  Matthew D. Troutman,et al.  Novel Experimental Parameters to Quantify the Modulation of Absorptive and Secretory Transport of Compounds by P-Glycoprotein in Cell Culture Models of Intestinal Epithelium , 2003, Pharmaceutical Research.

[10]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.

[11]  S. Chong,et al.  Cell culture-based models for intestinal permeability: a critique. , 2005, Drug discovery today.

[12]  P. Artursson,et al.  Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  K. Sandy Pang,et al.  Response to Letter to the Editor on “Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study” , 2010, Drug Metabolism and Disposition.

[14]  C. Anthony Hunt,et al.  Mechanistic simulations explain paradoxical saquinavir metabolism during in vitro vectorial transport study , 2009 .

[15]  Nipa Shah,et al.  Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay. , 2009, Molecular pharmaceutics.

[16]  Thomas J. Raub,et al.  Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. , 1995, Journal of pharmaceutical sciences.

[17]  A. Galetin,et al.  Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption. , 2009, Journal of pharmaceutical sciences.

[18]  Per Artursson,et al.  Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA method , 2005 .

[19]  C Anthony Hunt,et al.  Studies of intestinal drug transport using an in silico epithelio-mimetic device. , 2005, Bio Systems.

[20]  J. Mönkkönen,et al.  In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  Kristina Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .

[22]  J. Polli,et al.  The Steady-State Michaelis–Menten Analysis of P-Glycoprotein Mediated Transport Through a Confluent Cell Monolayer Cannot Predict the Correct Michaelis Constant Km , 2005, Pharmaceutical Research.

[23]  R. Toral,et al.  Drug absorption through a cell monolayer: a theoretical work on a non-linear three-compartment model. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  Michael B. Bolger,et al.  Simulations of the Nonlinear Dose Dependence for Substrates of Influx and Efflux Transporters in the Human Intestine , 2009, The AAPS Journal.

[25]  Ismael Zamora,et al.  pH-Dependent Bidirectional Transport of Weakly Basic Drugs Across Caco-2 Monolayers: Implications for Drug–Drug Interactions , 2003, Pharmaceutical Research.

[26]  Kerby Shedden,et al.  A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. , 2006, Molecular pharmaceutics.

[27]  Marjo Yliperttula,et al.  Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  T. Henzinger,et al.  Executable cell biology , 2007, Nature Biotechnology.

[29]  Z. Zuo,et al.  A Catenary Model to Study Transport and Conjugation of Baicalein, a Bioactive Flavonoid, in the Caco-2 Cell Monolayer: Demonstration of Substrate Inhibition , 2008, Journal of Pharmacology and Experimental Therapeutics.

[30]  P. van Hoogevest,et al.  Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  Michael B. Bolger,et al.  In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect , 2006, Pharmaceutical Research.

[32]  H. Lennernäs,et al.  Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. , 2007, Molecular pharmaceutics.

[33]  U. Fagerholm Prediction of human pharmacokinetics —gastrointestinal absorption , 2007, The Journal of pharmacy and pharmacology.

[34]  P. Artursson,et al.  Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.

[35]  J. Polli,et al.  Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.

[36]  M. Jamei,et al.  A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates. , 2009, Drug metabolism and pharmacokinetics.

[37]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .

[38]  J. Polli,et al.  The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells. , 2005, Biophysical journal.

[39]  G. Amidon,et al.  Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion , 1997, Pharmaceutical Research.

[40]  Ulf Norinder,et al.  Exploring the role of different drug transport routes in permeability screening. , 2005, Journal of medicinal chemistry.

[41]  P. Artursson,et al.  A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial caco 2 cells grown in permeable filter chambers , 1991 .

[42]  G. M. Pollack,et al.  Intestinal Absorptive Transport of the Hydrophilic Cation Ranitidine: A Kinetic Modeling Approach to Elucidate the Role of Uptake and Efflux Transporters and Paracellular vs. Transcellular Transport in Caco-2 Cells , 2006, Pharmaceutical Research.

[43]  J. Polli,et al.  Bias in Estimation of Transporter Kinetic Parameters from Overexpression Systems: Interplay of Transporter Expression Level and Substrate Affinity , 2007, Journal of Pharmacology and Experimental Therapeutics.

[44]  M. Zeidel,et al.  The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons , 1995, The Journal of general physiology.

[45]  J. Mönkkönen,et al.  Analysis of unstirred water layer in in vitro permeability experiments. , 2009, Journal of pharmaceutical sciences.

[46]  G. M. Pollack,et al.  Kinetic Considerations for the Quantitative Assessment of Efflux Activity and Inhibition: Implications for Understanding and Predicting the Effects of Efflux Inhibition , 2007, Pharmaceutical Research.

[47]  J. Mönkkönen,et al.  Kinetics of Cellular Retention during Caco-2 Permeation Experiments: Role of Lysosomal Sequestration and Impact on Permeability Estimates , 2009, Journal of Pharmacology and Experimental Therapeutics.

[48]  Mei-Ling Chen,et al.  Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities. , 2004, Journal of pharmaceutical sciences.

[49]  M. Bermejo,et al.  Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM , 2005, Xenobiotica; the fate of foreign compounds in biological systems.

[50]  Lana X Garmire,et al.  In Silico Methods for Unraveling the Mechanistic Complexities of Intestinal Absorption: Metabolism-Efflux Transport Interactions , 2008, Drug Metabolism and Disposition.

[51]  Aditya Mittal,et al.  Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier. , 2004, Journal of pharmaceutical sciences.

[52]  J. Mönkkönen,et al.  Decrease in Intracellular Concentration Causes the Shift in Km Value of Efflux Pump Substrates , 2007, Drug Metabolism and Disposition.

[53]  Sebastian Polak,et al.  Population-Based Mechanistic Prediction of Oral Drug Absorption , 2009, The AAPS Journal.

[54]  J. Mönkkönen,et al.  The Asymmetry of the Unstirred Water Layer in Permeability Experiments , 2008, Pharmaceutical Research.